Table 2.

Summary of the clinical data, histology, PSMA-MS-PCR, PSMA-mRNA, and PSMA expression

SamplePSMA-MS-PCR methylatedPSMA-RNAImmunohistochemistryFIGO gradeFIGO stageDepth of invasion %Tumor size in cmHistology type
941NoLowNegative1I826Endometrioid
943YesLowNegative3II17Endometrioid
957YesLowNegative3IV937Serous + clear
942NoLowPositive3II892.2Endometrioid
940YesLowNegative1II164.5Endometrioid
945YesLowNegative3I759Endometrioid + clear
947NoLowNegative1I65.5Endometrioid
946YesLowNegative2II906Endometrioid
932NoMediumNegative1I01.7Endometrioid
937NoMediumPositive3IV907.5Endometrioid
936NoMediumPositive2III874.5Endometrioid
938NoMediumNegative1I126Endometrioid
931NoMediumPositive1I02Endometrioid
933NoMediumPositive1I83.2Endometrioid
948NoHighPositive2I302.5Endometrioid
954NoHighPositive1I155Endometrioid
958NoHighNegative2I105.5Endometrioid
951NoHighPositive3I753Endometrioid
DU145Yes
HECLAYes
LNCAPNo
PC3Yes
RL-95Yes